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Objectives: Patients with Parkinson’s disease (PD) can be classified, based on their
motor symptoms into the Postural Instability Gait Difficulty (PIGD) subtype or the
Tremor Dominant (TD) subtype. Gray matter changes between the subtypes have
been reported using whole brain Voxel-Based Morphometry (VBM), however, the
evaluation of subcortical gray matter volumetric differences between these subtypes
using automated volumetric analysis has only been studied in relatively small sample
sizes and needs further study to confirm that the negative findings were not due to the
sample size. Therefore, we aimed to evaluate volumetric changes in subcortical regions
and their association with PD motor subtypes.
Methods: Automated volumetric magnetic resonance imaging (MRI) analysis quantified
the subcortical gray matter volumes of patients with PD in the PIGD subtype (n = 30),
in the TD subtype (n = 30), and in 28 healthy controls (HCs).
Results: Significantly lower amygdala and globus pallidus gray matter volume was
detected in the PIGD, as compared to the TD subtype, with a trend for an association
between globus pallidus degeneration and higher (worse) PIGD scores. Furthermore,
among all the patients with PD, higher hippocampal volumes were correlated with a
higher (better) dual tasking gait speed (r = 0.30, p < 0.002) and with a higher global
cognitive score (r = 0.36, p < 0.0001). Lower putamen volume was correlated with a
higher (worse) freezing of gait score (r = −0.28, p < 0.004), an episodic symptom which
is common among the PIGD subtype. As expected, differences detected between HCs
and patients in the PD subgroups included regions within the amygdala and the dorsal
striatum but not the ventral striatum, a brain region that is generally considered to be
more preserved in PD.
Conclusions: The disparate patterns of subcortical degeneration can explain some
of the differences in symptoms between the PD subtypes such as gait disturbances
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and cognitive functions. These findings may, in the future, help to inform a personalized
therapeutic approach.
Keywords: Parkinson’s disease, tremor, postural instability gait difficulty, volumetric MRI, basal ganglia, globus
pallidus, imaging, gait
INTRODUCTION
Patients with Parkinson’s disease (PD) can be classified based on
their motor symptoms into the Tremor Dominant (TD) or the
Postural Instability Gait Difficulty (PIGD) subtype, depending
on whether tremor or balance and gait disturbances are the
most pronounced symptoms (Jankovic et al., 1990). Patients
with the PIGD subtype have an increased risk for developing
cognitive deterioration (Lewis et al., 2005; Burn et al., 2006,
2012; Herman et al., 2015), dementia (Aarsland et al., 2003,
2009; Williams-Gray et al., 2007) and mood disturbances such
as depression or anxiety (Burn et al., 2012). Thus, in addition
to the differences in PD motor symptoms, behavioral evidence
suggests that the neurological substrate differs in the PIGD and
TD subtypes.
These motor, cognitive, and behavioral differences among the
PD subtypes likely reflect alternations in brain structure.
Structural changes detected using Magnetic Resonance
Imaging (MRI) have been used as biological markers of
neurodegeneration in PD (Whitwell and Josephs, 2007; Pereira
et al., 2012). Using Voxel-Based Morphometry (VBM), we
recently reported on widespread gray matter reduction in
the PIGD subtype, as compared to the TD subtype, in the
frontal, parietal, occipital, and temporal lobes as well as in
the parahippocampal gyrus, cerebellum, caudate nucleus and
amygdala (Rosenberg-Katz et al., 2013). While VBM enables
us to evaluate whole brain changes, it may suffer from errors
that might arise from registration and segmentation procedures,
especially in subcortical regions. Automated volumetric analysis
is considered to be less sensitive to registration errors and to
anatomical variability such as ventricular enlargement which
is common in neurological diseases and aging (Khan et al.,
2008). Therefore, while this technique also has its limitations,
it has been considered to be the gold-standard approach for
morphological analysis of MRI data in older adults (Fischl et al.,
2002, 2004). Recently, a study using this automated approach
found no differences in subcortical brain volumes between the
PD subtypes (Nyberg et al., 2015), however, the relatively small
number of subjects (12 and 9 for the PIGD and TD groups,
respectively) might explain the negative findings. Additional
study, using a larger cohort of patients with PD, is needed
in order to determine if the previously reported absence of
subcortical brain volume differences between the subtypes was
due to a small sample size.
In the current study, we used automated volumetric analysis
to evaluate differences in subcortical degeneration between the
TD (n = 30) and PIGD (n = 30) subtypes. Based on our
previous work, we expected to find a reduction in subcortical
gray matter volume in the PIGD compared to the TD subtype.
Specifically, we hypothesized that the PIGD subtype will
have smaller gray matter volumes within the caudate nucleus
(an area which is related to cognitive function), within the
amygdala (an area which may be involved in the affective
symptoms that are more common in this group), and within
the globous pallidus (a brain area that might relate to the
gait disturbances of the PIGD subtype as part of its role in
the sensorimotor and the associative circuit; Tremblay et al.,
2015).
MATERIALS AND METHODS
One-hundred and ten patients with idiopathic PD and 28 healthy
controls (HCs) were recruited for this study. This is a secondary
analysis of work designed to compare PD motor subtypes
(Herman et al., 2013; Rosenberg-Katz et al., 2013). All patients
were diagnosed by a movement disorders specialist as having
idiopathic PD (as defined by theUKBrain Bank criteria). Patients
and controls were excluded if they had major orthopedic disease,
acute illness, history of stroke, a diagnosis of dementia based
on DSM-IV criteria or a Mini Mental State Examination score
(MMSE)< 24 (Folstein et al., 1983), had a diagnosed psychiatric
disorder, or if they underwent brain surgery in the past. For the
HCs, exclusion criteria also included any neurological disease.
Protocol Outline
All subjects provided informed written consent prior to
participating in the study, as approved by the Human Research
Ethics Committee of Tel Aviv Sourasky Medical Center. Patients
were studied on two separate occasions: the first visit included
a neurological and clinical examination. On a separate visit that
took place within 2 weeks after the first visit, the participants
underwent MRI testing in the ‘‘ON’’ medication state.
Clinical Evaluation
Patients underwent a clinical assessment that included the
Unified Parkinson’s Disease Rating Scale (UPDRS). The pull
test (item 30 of the UPDRS) was used as a measure of balance
and postural control. Usual and dual tasking gait speed (m/s)
under single and dual task conditions (i.e., serial 3 subtracting)
was determined as a measure of gait difficulties (Herman
et al., 2014). These assessments were conducted in the ‘‘OFF’’
state after at least 12 h of overnight withdrawal of anti-
parkinsonian medications. A computerized cognitive battery
(NeuroTrax Corp., Modiin, Israel) (Dwolatzky et al., 2003) was
used in the ‘‘ON’’ state to sample a wide range of cognitive
domains and to generate a normalized global cognitive score.
To evaluate confidence while walking and fear of falling, the
Activities-specific Balance Confidence (ABC) scale (Powell and
Myers, 1995) was used. Emotional well-being and depressive
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TABLE 1 | Demographic characteristics of the study participants.
Healthy Indeterminate PIGD TD p-value
controls patients (PIGD vs. TD)
Number of subjects 28 45 30 30
Age (years) 64.91 ± 8.76 65.16 ± 8.43 64.95 ± 7.71 64.60 ± 8.85 0.90
Female/male 12/16 36/9 12/18 7/23 0.08
Years of education 16.01 ± 3.45 15.34 ± 3.22 15.80 ± 3.90 15.00 ± 3.30 0.33
Disease duration (years) NA 5.62 ± 5.50 5.69 ± 3.68 5.36 ± 3.15 0.90
LED (mg) NA 343.00 ± 430.73 582.12 ± 341.45 488.23 ± 284.13 0.25
UPDRS motor sum NA 41.85 ± 14.70 38.74 ± 10.47 39.47 ± 15.30 0.80
PIGD score NA 4.65 ± 2.58 7.29 ± 3.10 1.84 ± 0.88 0.00001
Tremor score NA 7.43 ± 5.97 1.52 ± 0.93 11.88 ± 3.55 0.00001
New freezing of gait questionnaire NA 4.50 ± 7.66 8.16 ± 9.88 0 ± 0 0.0001
Usual-walking gait speed (m/s) 1.15 ± 0.14 1.09 ± 0.21 1.07 ± 0.19 1.21 ± 0.19 0.002
Dual tasking gait speed (m/s) 1.07 ± 0.19 0.98 ± 0.25 0.90 ± 0.27 1.06 ± 0.20 0.009
Global cognitive score 95.88 ± 9.43 94.49 ± 10.70 90.04 ± 14.39 95.89 ± 10.79 0.073
Geriatric depression scale NA 3.96 ± 3.20 4.70 ± 3.14 3.00 ± 3.19 0.04
Activities-specific balance confidence scale NA 84.50 ± 16.50 79.20 ± 17.00 94.55 ± 7.84 0.0003
LED, Levodopa equivalent dosage; UPDRS, Unified Parkinson’s Disease Rating Scale; NA, not available.
TABLE 2 | Volumetric comparisons in the selected regions of interest (ROIs) between the postural instability gait difficulty (PIGD) subtype, tremor
dominant (TD) subtype and HCs.
Region Estimated Estimated Estimated Group (healthy
mean controls mean PIGD mean TD controls, PIGD and
(n = 28) (n = 30) (n = 30) TD subtypes)
F value (p-value)
Cerebellum 50513 ± 1420 49304 ± 1317 49567 ± 1403 0.21 (0.81)
Thalamus 6303 ± 126 6430 ± 118 6653 ± 89 1.78 (0.18)
Caudate 3707 ± 99 3287 ± 91 3363 ± 97 5.34 (0.007)
Putamen 4947 ± 109 4475 ± 101 4738 ± 108 5.29 (0.007)
Globus pallidus 1397 ± 37 1387 ± 35 1509 ± 37 3.20 (0.046)
Hippocampus 3824 ± 52 3724 ± 87 3817 ± 77 0.41 (0.66)
Amygdala 1693 ± 50 1391 ± 46 1535 ± 50 9.95 (0.0001)
Nucleus accumbens 586 ± 20 539 ± 18 561 ± 19 1.63 (0.20)
symptoms were assessed using the 15-item version of the
Geriatric Depression Scale (Yesavage et al., 1982). Balance and
postural control were evaluated using the Berg Balance Scale
(BBS; Berg et al., 1992). Patients also completed the New Freezing
of Gait Questionnaire (N-FOGQ; Nieuwboer et al., 2009). The
daily levodopa equivalent dosage (LED) was calculated for each
patient as previously described (Tomlinson et al., 2010).
Classification into PIGD and TD Subtypes
From the 110 patients that were recruited for this study,
automated volumetric analysis was conducted on 105 patients
(5 patients did not complete the MRI scans). These patients
were classified into the PIGD or TD subtypes as previously
described (Rosenberg-Katz et al., 2013). Briefly, symptoms were
first quantified by summing specific items from the UPDRS to
determine PIGD and TD scores that reflect gait and balance
difficulties and tremor severity, respectively (Jankovic et al.,
1990). Patients were classified to PIGD or TD group based on
the ratio between the PIGD and tremor scores. Then, in order
to stratify the patients into groups who best represented the two
subtypes, with minimal overlap across symptom classes, patients
were excluded from the TD group if they had a PIGD score higher
than 3 or a tremor score lower than 4. Similarly, patients were
excluded from the PIGD group if their PIGD score was lower
than 4 or their tremor score was higher than 3 (Rosenberg-Katz
et al., 2013). Patients who did not meet the criteria for one of the
groups were considered as indeterminate. Thirty PIGD patients,
30 TD patients, and 45 indeterminate patients were identified.
MRI Acquisition
All of the MR images were acquired on a 3.0 T (GE) scanner
using an 8-channel head coil. A high-resolution T1-weighted
brain volume (BRAVO) acquisition was used with the following
parameters: repetition time (TR) = 9000 ms, echo time (TE) =
3.6 ms, flip angle (FA) = 90◦, voxel size = 1× 1× 1, matrix = 256
× 256, field of view (FOV) = 250× 250 mm2.
Volumetric Analysis
The automated volume-based stream was performed on axial 3D
T1-weighted BRAVO images using the FreeSurfer V5.1 image
analysis suite, well documented and freely available software1
(Fischl et al., 2002, 2004).
1http://surfer.nmr.mgh.harvard.edu/
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Processing included affine transformation of each
participant’s T1 weighted image into Talairach space,
probabilistic segmentation of gray and white matter structures,
bias field intensity normalization, and automated labeling
of anatomical regions of interest (ROIs) in both cerebral
hemispheres (Fischl et al., 2002, 2004). The ROIs derived from
this analysis were the same as those examined by Nyberg
et al. (2015) and included the thalamus, the caudate nucleus,
the putamen, the globus pallidus, the amygdala, the nucleus
accumbens, and the hippocampus. While there is some
disagreement about whether the hippocampus should be
considered as a subcortical region, it was included as it is part
of the limbic system and to compare with the work of Nyberg
et al. (2015). For each patient, the ROIs contralateral to the
more affected side, defined by the side with a higher score on
the UPDRS, were examined. For the HCs, and patients with no
dominant affected side, the mean value of both hemispheres was
used for comparisons.
Statistical Analysis
All statistical analyses were two-sided and conducted using
the Statistical Package for Social Sciences (Version 20; SPSS
Inc., Chicago, IL, USA). Multivariate analysis of covariance
(MANCOVA) adjusted for age and total intracranial volume was
used to compare ROIs volumes across PIGD, TD subgroups and
controls. Similar analyses which also included the indeterminate
patients were also performed to evaluate if this group had
ROIs volumes in between the values seen in the two subtypes.
As these regions were predefined, no correction for multiple
comparisons was performed in this analysis. For all correlation
analyses, partial correlations were conducted adjusting for age
and total intracranial volume. For patients with PD, correlations
between gray matter brain volumes and PIGD score, tremor
score, gait speed (usual and dual tasking), N-FOGQ, global
cognitive score, ABC scale, and Geriatric Depression Scale (GDS)
were conducted in the entire sample (n = 105), including the
indeterminate group, and were adjusted for age, disease duration
and total intracranial volume. Outliers were defined as values
larger than 2 interquartile ranges above the 75th percentile or
lower than 2 interquartile ranges below the 25th percentile,
however, no outliers were detected. Bonferroni corrections for
multiple comparisons were also applied for these correlation
analyses.
RESULTS
Patient Characteristics
There were no significant differences between the PIGD and
TD groups in their demographic characteristics including age,
gender, years of education, UPDRS motor scores, disease
duration, and LED (see Table 1). As expected, axial motor
impairments were more severe in the PIGD group than in the
TD group, as measured by the pull test and the BBS. Usual
and dual tasking gait speeds were lower in the PIGD subtype.
The executive function index from the computerized cognitive
battery, Mini Mental Status Exam (MMSE) scores and global
FIGURE 1 | Volumetric differences in selected regions between the TD
subtype, the PIGD subtype and controls. TD, tremor dominant; PIGD,
Postural Instability Gait Difficulty. ∗p < 0.05, ∗∗p < 0.005.
cognitive scores tended to be lower in the PIGD group than in the
TD group; however, these group differences were not significant
(Table 1). Patients with the PIGD subtype also had worse scores
on the ABC scale and GDS, respectively.
Volumetric Analysis
MANCOVA analysis including the PIGD group, the TD group,
and HCs detected a significant GROUP effect within the caudate,
putamen, globus pallidus and amygdala. The estimated marginal
means adjusted for age and intracranial volume are presented in
Table 2 and Figure 1. Post hoc analysis showed that the PIGD
patients had lower gray matter volumes in the globus pallidus
and amygdala, as compared to the patients with the TD subtype.
TABLE 3 | p-values for post hoc comparisons between the PIGD subtype,
TD subtype and HCs.
Region PIGD vs. TD PIGD vs. controls TD vs. controls
Cerebellum n.s n.s n.s
Thalamus n.s n.s n.s
Caudate n.s 0.001 0.020
Putamen n.s (p = 0.08) 0.002 n.s
Globus pallidus 0.02 n.s 0.045
Hippocampus n.s n.s n.s
Amygdala 0.04 0.0003 0.036
Nucleus accumbens n.s n.s n.s
n.s, non-significant.
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TABLE 4 | Volumetric comparisons in the selected ROIs between the PIGD subtype, TD subtype, indeterminate patients and HCs.
Region Estimated Estimated Estimated Estimated Group (healthy
Mean controls Mean PIGD Mean Mean TD controls, PIGD,
(n = 28) (n = 30) indeterminate (n = 30) indeterminate, and
(n = 45) TD subtypes)
F value (p-value)
Cerebellum 50768 ± 1556 49444 ± 1457 50709 ± 1186 49617 ± 1512 0.25 (0.86)
Thalamus 6330 ± 129 6447 ± 121 6376 ± 99 6647 ± 126 1.24 (0.29)
Caudate 3682 ± 95 3290 ± 89 3364 ± 72 3413 ± 92 3.50 (0.02)
Putamen 4960 ± 109 4487 ± 102 4498 ± 83 4735 ± 106 5.05 (0.002)
Globus pallidus 1415 ± 35 1396 ± 33 1419 ± 27 1496 ± 34 1.64 (0.19)
Hippocampus 3808 ± 65 3722 ± 80 3907 ± 65 3841 ± 83 1.09 (0.36)
Amygdala 1684 ± 49 1391 ± 46 1529 ± 37 1551 ± 48 6.63 (0.0003)
Nucleus accumbens 589 ± 20 540 ± 19 556 ± 15 560 ± 20 1.13 (0.34)
Both the PIGD and TD subtypes had lower caudate nucleus
and amygdala volumes, as compared to HCs. The PIGD subtype
also had a lower putamen gray matter volume compared to the
controls (see Table 3 and Figure 1).
Additional MANCOVA analyses which included the
indeterminate group as well as the PIGD subtype, the TD
subtype, and HCs showed a similar pattern of results with a
significant GROUP effect within the caudate, putamen, and
amygdala (see Tables 4, 5 and Figure 2). While the globus
pallidus only showed a small trend for a group effect (p =
0.19), post hoc comparisons still showed a significant difference
between the PIGD and TD subtypes (p< 0.04, seeTable 5) within
this region. Interestingly, in the regions showing a significant
GROUP effect, the volumes of the indeterminate group were
between the volumes of the two subtypes (see Table 4 and
Figure 2). Furthermore, the amygdala volume was significantly
larger in the indeterminate group than in the PIGD subtype,
while no significant difference between the indeterminate group
and the two PD subtypes were detected for the other regions (see
Table 5).
Among all of the patients with PD (n = 105), higher
hippocampal volumes were correlated with higher dual tasking
gait speed (r = 0.30, p < 0.002) and with higher global cognitive
score (r = 0.36, p < 0.0001; see Figure 3). Higher (worse)
scores on the N-FOGQ were correlated with lower putamen
gray matter volumes (r = −0.28, p < 0.004; see Figure 3).
No significant correlations were detected between gray matter
volumes and tremor or the PIGD scores, however, using a more
liberal threshold, the PIGD score was mildly associated with
lower globus pallidus volume (r =−0.22, p< 0.03; see Figure 3),
but not when corrected for multiple comparisons.
DISCUSSION
In this study, greater amygdala and globus pallidus gray matter
loss were detected in the PIGD, as compared to the TD
subtype. In addition, the PIGD subtype had significantly higher
putamen degeneration than controls. Interestingly, the putamen
volumes in the TD subtype were not significantly different
than controls. Furthermore, increased putamen degeneration
was associated with a higher (worse) freezing of gait score,
an episodic symptom which is more associated with the
PIGD subtype and likely involves a motor-cognitive failure
(Giladi et al., 2007; Fasano et al., 2011; Cohen et al., 2014;
Maidan et al., 2015). As might be expected, indeterminate
PD patients, who have a mixture of symptoms of both
subtypes, had an intermediate volume between the subtypes in
regions where a significant difference between the groups was
observed.
Patients with PD had lower subcortical volumes within
the amygdala and the dorsal striatum (caudate and putamen),
as compared to HCs. The dorsal striatum is believed to be
especially sensitive to PD, and this atrophy is considered to
be a marker for neurodegeneration, as it is shown to be
associated with the stages and severity of the disease (Pereira
et al., 2012). In contrast, no differences were found within the
ventral striatum (nucleus accumbens) which is considered to
be more preserved in PD, based on the localized accumulation
TABLE 5 | p-values for post hoc comparisons between the PIGD subtype, TD subtype, indeterminate patients and HCs.
Region PIGD vs. TD PIGD vs. controls TD vs. controls Indeterminate PIGD vs. TD vs.
vs. controls indeterminate indeterminate
Cerebellum n.s n.s n.s n.s n.s n.s
Thalamus n.s n.s n.s n.s n.s n.s
Caudate n.s 0.003 0.05 0.009 n.s n.s
Putamen n.s (p = 0.2) 0.002 n.s 0.001 n.s n.s
Globus pallidus 0.04 n.s n.s n.s n.s n.s
Hippocampus n.s n.s n.s n.s n.s n.s
Amygdala 0.018 0.0002 n.s (0.059) 0.013 0.02 n.s
Nucleus accumbens n.s n.s n.s n.s n.s n.s
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FIGURE 2 | Volumetric differences in selected regions between the TD
subtype, the PIGD subtype, indeterminate patients and controls. TD,
tremor dominant; PIGD, Postural Instability Gait Difficulty. ∗p < 0.05,
∗∗p < 0.005.
of Lewy bodies (Braak et al., 2003). Based on the role of
the caudate nucleus in cognition as part of the associative
corticostriatal circuit (Alexander et al., 1986; Tremblay et al.,
2015), we would expect to find reduced caudate nucleus
volumes in patients of the PIGD subtype, as they have a
higher risk for developing cognitive impairment (Lewis et al.,
2005; Burn et al., 2006, 2012; Herman et al., 2015). Perhaps
the role of the caudate nucleus in cognition is also affected
by its functional connectivity with other brain regions, as
previously demonstrated in patients with PD (Vervoort et al.,
2016).
The increased pallidal degeneration in the PIGD subgroup,
as compared to the TD subgroup, may partially explain a
range of motor and non-motor symptoms common in the
PIGD subgroup. Indeed, the globus pallidus is involved in
the sensorimotor, associative and limbic corticostriatal circuits
(Alexander et al., 1986). These three circuits play a role in
many aspects of action planning, starting from motivational
information for goal selection through the limbic circuit,
continuing with action selection via the associative circuit,
and concluding with movement selection and execution by
the sensorimotor circuit (Tremblay et al., 2015). The gait
disturbances, which are highly representative of the PIGD
subtype, can be related to both the impairment of the
sensorimotor and the associative circuit.
Amygdala degeneration was detected in both subtypes, as
compared to HCs, with greater degeneration in the PIGD
subtype, compared to the TD subtype and to the indeterminate
group. This is consistent with a previous report that compared
PD subjects without dementia to controls (Bouchard et al.,
2008) and with our previous VBM analysis (Rosenberg-Katz
et al., 2013). The detected changes in amygdala volume can be
related to a number of affective (non-motor) symptoms in PD,
including depression, apathy, compulsive behavior, and anxiety
(Chaudhuri et al., 2006). Depression and anxiety were more
severe in the PIGD subtype than in the TD subtype (Burn et al.,
2012), which is consistent with our findings of greater level of
fear of falling (reflected by the lower balance confidence scores)
and higher depression scores in the PIGD subtype. Nonetheless,
we could not detect any significant correlations between these
measurements and amygdala gray matter volume. Perhaps a
latent variable, possibly within the limbic system, mediates those
relationships.
The detected correlations between hippocampal volumes with
both global cognitive score and dual tasking gait speed are
consistent with previously reported associations between lower
hippocampus volume and reduced gait speed and step length
in non-PD older adults (Callisaya et al., 2013). Similarly, lower
hippocampal volume and metabolism (measured using MR
spectroscopy) have been associated with poorer stride length in
older adults without dementia (Zimmerman et al., 2009). Overall,
our findings support the suggested relationships between gait
and cognition (Amboni et al., 2013), possibly via the role of
the hippocampus in spatial orientation and memory (O’Keefe
et al., 1998). The lack of hippocampal differences between the
groups is consistent with other volumetric studies in PD, which
found lower hippocampus volumes in patients with PD-related
dementia as compared to patients with no dementia (Zarei
et al., 2013; Xu et al., 2016), while no changes were detected
when comparing PD patients with mild cognitive impairment
to PD patients with no cognitive impairment, suggesting that
the hippocampal atrophy in PD is a gradual progressive process
(Xu et al., 2016).
Interestingly, higher globus pallidus volumes were detected
in the TD group, as compared to both controls and patients
in the PIGD group. This observation is consistent with
previous VBM studies which showed that PD tremor and
essential tremor are associated not only with atrophy of
brain regions but also with cortical enlargement. For example,
enlargement of posterior parts of the thalamus was present in
PD patients with tremor, as compared to controls (Kassubek
et al., 2002; Lin et al., 2013). In our cohort, there was a
trend for increased thalamic volume in the tremor subtype,
although this was not significant. The direct relationship
between the globus pallidus and the thalamus within the
direct basal ganglia-thalamocortical circuit may explain the
enlargement of both of these regions. This enlargement might
reflect a compensatory mechanism in response to damage to
the basal ganglia-thalamocortical circuit. Another possibility
is that patients in the TD subtype are initially protected
from globus pallidus and thalamic degeneration and this
is why they have early tremor and not PIGD symptoms.
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FIGURE 3 | Scatter plots for the significant correlations detected between gray matter volumes and behavioral measurements.
Indeed, a functional MRI study reported higher functional
activation of the globus pallidus in patients with tremor
dominant PD, as compared to those without (Prodoehl et al.,
2013). The nature of this enlargement, either as a result of
neuronal hypertrophy or by a higher density of neurons,
can only be determined using post-mortem pathological
investigations.
The volumetric differences that were found in the present
study between the PD subtypes are not in agreement with a
recent study which did not find volumetric changes in these same
subcortical regions (Nyberg et al., 2015). Several possibilities
might explain this discrepancy. First, our analysis included 30
patients in each group of the PD subtypes while Nyberg et al.
(2015) included only nine PIGD and 12 TD patients. Second,
we used additional restrictions for the traditional stratification
into the PD subtypes (Jankovic et al., 1990), in order to exclude
patients with mixed symptoms from the analysis (Rosenberg-
Katz et al., 2013). This stricter stratification may enable the
detection of subtle changes between the two PD subtypes. Further
work is needed to confirm the results of the present study and
better understand these differences.
Previous whole-brain VBM analysis on the same cohort
(Rosenberg-Katz et al., 2013) detected widespread frontal,
parietal, occipital, and temporal gray matter reduction in the
PIGD subtype as compared to the TD subtype, as well as changes
in the parahippocampal gyrus, cerebellum, caudate nucleus, and
amygdala. While the changes in the amygdala were consistent
using both types of analysis, we could not detect any group
differences within the cerebellum and the caudate nucleus. This
discrepancy could be related to the type of analysis that was used.
Indeed, it has been suggested that automated volumetric analysis
is less affected by anatomical variability, especially in subcortical
structures (Fischl et al., 2002, 2004) than VBM.
To conclude, the detected gray matter atrophy in subcortical
areas can potentially explain some of the motor, cognitive and
affective symptoms that are different among the PD subtypes.
These anatomical changes suggest that subcortical degeneration
is not distributed similarly across the two PD motor subtypes
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and support the possibility that different therapeutic approaches
should be considered for each of the motor PD subtypes.
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